CCL2 and posterior cortical atrophy: In the context of SFM-DR and alternative survival pathway activation in CRPC, chemokine (C-C motif) ligand 2 (CCL2; monocyte-chemoattractant protein-1) has been reported to be a prominent modulator of metastatic growth of PCa in bone [88].